VX-864
VX22-864-108
Phase 2 small_molecule terminated
Quick answer
VX-864 for Alpha-1 Antitrypsin Deficiency is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Alpha-1 Antitrypsin Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated